STAND.
COM. REP. NO. 924-22
Honolulu, Hawaii
, 2022
RE: H.B. No. 2340
H.D. 2
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirty-First State Legislature
Regular Session of 2022
State of Hawaii
Sir:
Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 2340, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES,"
begs leave to report as follows:
Your Committee received testimony in support of this measure from Kaiser Permanente Hawai‘i and one individual. Your Committee received comments on this measure from the Board of Pharmacy.
Your Committee finds that the high volume of prescriptions necessitates a closer examination of ways to improve efficiencies while ensuring patient and public safety. Under existing law, if a controlled substance prescription has a post office box address, pharmacists are required to verify a patient's identification, note the identification number on the prescription, and change the address to a physical location, such as a street address, tax map key, or description of the physical location. This measure eliminates these steps only if the physical address is on file, which will reduce the administrative burden on pharmacists while still maintaining safety and effective chain of custody of controlled substances.
Your Committee has amended this measure by making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2340, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 2340, H.D. 2.
Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,
|
|
|
____________________________ AARON LING JOHANSON, Chair |
|
|
|
|